WGRX wellgisticshealth.com: Enterprise Value to EBITDA Ratio

Wellgistics Health Inc (WGRX) efficiency is based on deep digital synchronization with pharmaceutical manufacturers, eliminating reliance on external carriers. The company generates revenue through the wholesale supply of prescription drugs to regional clinics and private pharmacies. This price chart, with a value of 0.00, confirms the stability of a business built on long-term B2B agreements and the predictable returns of an advanced logistics system.

Wellgistics Health, Inc. - WGRX Company Value to EBITDA (period 11/23/2025 - 07/22/2026)

wellgisticshealth.com (WGRX) - metric breakdowns and financial figures

- stock price and consensus target price:

Stock Quotes Wellgistics Health|WGRX - Average Forecast Price

- company stock capitalization data:

Market Valuation Wellgistics Health Inc|WGRX - Real Price to Acquire Entire Company

- business book valuation details:

Book Value per Share Wellgistics Health|WGRX - Total Stockholders' Equity|Market Value to Book Value Ratio wellgisticshealth.com|WGRX - Aggregate Company Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

WGRX - Profit After Payment of Taxes|Projected Future Earnings Wellgistics Health Inc|WGRX - Business Payback Period|Forward P/E Multiple Wellgistics Health|WGRX - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Wellgistics Health Inc|WGRX - Operating income before deduction of amortization|Net earnings per share for the last 12 months Wellgistics Health|WGRX - Earnings per share for the trailing year|Quarterly EPS earnings growth wellgisticshealth.com|WGRX - Earnings per share increase in current year|Earnings growth forecast for next year Wellgistics Health Inc

- revenue and sales details:

WGRX - Company Total Revenue|Projected Sales Volume Wellgistics Health|WGRX - P/S Multiple|Price-to-Projected Revenue Ratio Wellgistics Health Inc

Basic company analysis:Wellgistics WGRX

Original product of wellgisticshealth.com

The EV/EBITDA multiple reflects the market status of Wellgistics Health Inc. (WGRX) as a key link in pharmaceutical distribution for small pharmacies. This multiple determines the payback period for the total enterprise value through operating profit, excluding the impact of taxes and debt load. The metric's sensitivity to changes in enterprise value allows investors to promptly identify whether the asset is overvalued or undervalued. The stability of this indicator confirms the resilience of the company's business model within the supply chain.

Analysis of competing companies

CVS Health - Enterprise Value to EBITDA Ratio|McKesson Group (MCK) - Company Value to EBITDA|COR: Enterprise Value to EBITDA Ratio|cardinalhealth.com (CAH) - Enterprise Value to EBITDA Ratio|HSIC: EV/EBITDA Multiple|Company Value to EBITDA Prestige Brands (PBH)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization 111, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RDGT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Universe Pharmaceuticals (UPC)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BDRX (biodexapharma.com)|EV/EBITDA Multiple HKPD (Hong Kong Pharma Digital Limited)|Enterprise Value to EBITDA Multiple BIMI Holdings, Inc.|Jiuzhou 360 - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Walgreens Boots Alliance WBA